Details for 2011738802
Up to date per 03.04.2026
Actions
Details for 2011738802
Granted/Registered
European Patent
20.03.2013 A
25.12.2013 B1
12.05.2010
US
395448 P
C07C 11/21 20060101AFI20111129BHEP
Owner
Seqirus UK LimitedPoint, 29 Market Street Maidenhead, Berkshire SL6 8AAGB
Representative
Representative
Gibler & Poth Patentanwälte KGDorotheergasse 7/141010 WienAT
Inventor
HORA, ManinderNektar Therapeutics 455 Mission Bay Boulevard South San Francisco, CA 94158US
Information about Fees